Alan Cass

Q: What Schools Are Affiliated With Alan Cass

Alan Cass is affiliated with the following schools: Monash University, Charles Darwin University, University of Queensland, University of New South Wales, University of Sydney, University of Melbourne

Alan Cass's AcademicInfluence.com Rankings

Alan Cass

Philosophy

#8794

World Rank

#12241

Historical Rank

Logic

#5812

World Rank

#7252

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Alan Cass's Degrees

Masters Medicine University of Melbourne
PhD Medicine University of Melbourne

Why Is Alan Cass Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alan Cass's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (2011) (2093)
Worldwide access to treatment for end-stage kidney disease: a systematic review (2015) (1375)
Hydroxyethyl starch or saline for fluid resuscitation in intensive care. (2012) (1209)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
Intensity of continuous renal-replacement therapy in critically ill patients. (2009) (815)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (801)
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. (2009) (388)
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials (2009) (380)
A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. (2003) (352)
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial (2017) (317)
Sharing the true stories: improving communication between Aboriginal patients and healthcare workers (2002) (300)
Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis (2013) (272)
How can we achieve global equity in provision of renal replacement therapy? (2008) (267)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial* (2012) (244)
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine (2017) (243)
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease (2010) (213)
Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. (2012) (212)
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials (2013) (203)
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis (2008) (199)
The cost‐effectiveness of increasing kidney transplantation and home‐based dialysis (2009) (193)
Effects of Allopurinol on the Progression of Chronic Kidney Disease. (2020) (183)
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. (2010) (183)
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. (2014) (178)
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy (2009) (177)
Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. (2013) (168)
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. (2010) (166)
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk (2015) (147)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study) (2010) (145)
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. (2009) (143)
Effects of fibrates in kidney disease: a systematic review and meta-analysis. (2012) (141)
Effects of lowering LDL cholesterol on progression of kidney disease. (2014) (140)
The Economic Impact of End Stage Kidney Disease in Australia (2006) (140)
Proteinuria and stroke: a meta-analysis of cohort studies. (2009) (136)
Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. (2011) (133)
Late referral to a nephrologist reduces access to renal transplantation. (2003) (132)
Gaps in cardiovascular disease risk management in Australian general practice (2009) (127)
Ten principles relevant to health research among Indigenous Australian populations (2012) (124)
Access to renal transplantation among American Indians and Hispanics. (2004) (117)
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. (2020) (115)
Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial (2014) (113)
The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis (2012) (109)
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. (2009) (107)
Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
Addressing inequities in access to quality health care for indigenous people (2008) (105)
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. (2007) (104)
The Study of Environment on Aboriginal Resilience and Child Health (SEARCH): study protocol (2010) (104)
Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians. (2004) (102)
Chronic kidney disease in the general population. (2005) (100)
High prevalence of chronic kidney disease in Thailand. (2008) (99)
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries. (2016) (98)
Survival outcomes of supportive care versus dialysis therapies for elderly patients with end‐stage kidney disease: A systematic review and meta‐analysis (2016) (97)
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. (2013) (96)
Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (2015) (93)
Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. (2010) (88)
Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis (2002) (86)
“All they said was my kidneys were dead”: Indigenous Australian patients’ understanding of their chronic kidney disease (2008) (83)
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review. (2016) (82)
Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. (2010) (81)
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. (2010) (79)
Survival of elderly dialysis patients is predicted by both patient and practice characteristics. (2012) (77)
Aboriginal and Torres Strait Islander people's domains of wellbeing: A comprehensive literature review. (2019) (76)
Limited knowledge of kidney disease in a survey of AusDiab study participants (2008) (76)
Preoperative Estimates of Glomerular Filtration Rate as Predictors of Outcome after Surgery: A Systematic Review and Meta-analysis (2013) (76)
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. (2014) (73)
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? (2015) (73)
Research Priorities in CKD: Report of a National Workshop Conducted in Australia. (2015) (73)
Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit (2009) (72)
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial (2017) (71)
Renal Transplantation for Indigenous Australians: Identifying the Barriers to Equitable Access (2002) (69)
Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. (2008) (69)
Community Preferences for the Allocation of Solid Organs for Transplantation: A Systematic Review (2010) (68)
Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis. (2010) (68)
End-stage renal disease in indigenous Australians: a disease of disadvantage. (2002) (67)
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. (2015) (65)
Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. (2013) (62)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Outcomes of extended-hours hemodialysis performed predominantly at home. (2013) (60)
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) (2016) (60)
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) (2016) (60)
Access to renal transplantation for minority patients with ESRD in Canada. (2004) (59)
A Trial of Extending Hemodialysis Hours and Quality of Life. (2017) (59)
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study (2009) (59)
Blood Pressure Is a Major Risk Factor for Renal Death: An Analysis of 560 352 Participants From the Asia-Pacific Region (2009) (57)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. (2013) (57)
The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study (2016) (55)
Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). (2012) (54)
What factors influence people's decisions to register for organ donation? The results of a nominal group study (2014) (51)
Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. (2010) (51)
Barriers to access by Indigenous Australians to kidney transplantation: The IMPAKT study (2004) (51)
Trends in the incidence of treated end‐stage kidney disease among Indigenous Australians and access to treatment (2007) (51)
Strategies to improve adherence to medications for cardiovascular diseases in socioeconomically disadvantaged populations: a systematic review. (2013) (49)
Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. (2008) (48)
Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand (2011) (48)
Low uptake of Aboriginal interpreters in healthcare: exploration of current use in Australia’s Northern Territory (2017) (47)
Cause of death in patients with end‐stage renal disease: assessing concordance of death certificates with registry reports (2003) (46)
Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. (2012) (46)
Physical inactivity and chronic kidney disease in Australian adults: the AusDiab study. (2011) (46)
Calorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial (2014) (45)
Cyclosporine Withdrawal Improves Long-Term Graft Survival in Renal Transplantation (2009) (45)
The design and rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE). (2013) (45)
“Looking back to my family”: Indigenous Australian patients’ experience of hemodialysis (2012) (44)
Timing of Renal Replacement Therapy and Patient Outcomes in the Randomized Evaluation of Normal Versus Augmented Level of Replacement Therapy Study* (2014) (43)
Study Protocol - Accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR Study (2010) (43)
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis. (2016) (42)
Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis. (2013) (42)
Facilitating engagement through strong relationships between primary healthcare and Aboriginal and Torres Strait Islander peoples (2016) (42)
Community Attitudes to Deceased Organ Donation: A Focus Group Study (2012) (41)
If you can't comply with dialysis, how do you expect me to trust you with transplantation? Australian nephrologists' views on indigenous Australians' 'non-compliance' and their suitability for kidney transplantation (2012) (41)
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk (2010) (41)
Accurate assessment of kidney function in indigenous Australians: the estimated GFR study. (2012) (41)
Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis (2017) (41)
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. (2008) (40)
Assessment of kidney function in type 2 diabetes (2010) (40)
Building better systems of care for Aboriginal and Torres Strait Islander people: findings from the Kanyini health systems assessment (2012) (40)
Health outcomes in Aboriginal populations (2004) (39)
Urban disadvantage and delayed nephrology referral in Australia. (2003) (38)
The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality (2011) (38)
The RENAL (Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy) study: statistical analysis plan. (2009) (37)
The health-related quality of life of Indigenous populations: a global systematic review (2016) (37)
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. (2017) (36)
Study Protocol – Improving Access to Kidney Transplants (IMPAKT): A detailed account of a qualitative study investigating barriers to transplant for Australian Indigenous people with end-stage kidney disease (2008) (35)
Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). (2014) (34)
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD (2016) (34)
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial. (2016) (34)
Bridging the treatment gap for Indigenous Australians (2005) (33)
The Honeypot Study Protocol: A Randomized Controlled Trial of Exit-Site Application of Medihoney Antibacterial Wound Gel for the Prevention of Catheter-Associated Infections in Peritoneal Dialysis Patients (2009) (33)
Early acid–base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis (2013) (32)
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. (2022) (32)
Decision‐making about suitability for kidney transplantation: Results of a national survey of Australian nephrologists (2007) (32)
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration. (2013) (32)
Disparity of access to kidney transplantation by Indigenous and non‐Indigenous Australians (2018) (31)
Nephrologists' perspectives on waitlisting and allocation of deceased donor kidneys for transplant. (2011) (30)
COnsiderations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment. (2014) (30)
The risk of cancer in people with diabetes and chronic kidney disease. (2012) (30)
Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. (2005) (30)
Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence (2016) (30)
Patient preferences for the allocation of deceased donor kidneys for transplantation: a mixed methods study (2012) (29)
High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study (2018) (29)
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation (2017) (29)
How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. (2014) (28)
Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study (2017) (28)
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial. (2015) (27)
What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study (2011) (27)
They really want to go back home, they hate it here: the importance of place in Canadian health professionals' views on the barriers facing Aboriginal patients accessing kidney transplants. (2009) (27)
Can economic incentives increase the use of home dialysis? (2018) (27)
Interventions for erythropoietin-resistant anaemia in dialysis patients. (2013) (27)
Daily Protein Intake and Patient Outcomes in Severe Acute Kidney Injury: Findings of the Randomized Evaluation of Normal versus Augmented Level of Replacement Therapy (RENAL) Trial (2014) (26)
Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study (2014) (26)
Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose (2015) (26)
Evidence-based care in a population with chronic kidney disease and acute coronary syndrome. Findings from the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE). (2015) (25)
3. Measuring health inequalities (2004) (25)
Increasing home based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis (2011) (25)
The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapy. (2014) (25)
Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study (2011) (24)
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP) (2016) (24)
Health‐related quality of life in survivors of acute kidney injury: The Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes (2015) (24)
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP) (2016) (24)
Australian nephrologists' attitudes towards living kidney donation. (2006) (24)
Difficult conversations: Australian Indigenous patients’ views on kidney transplantation (2017) (24)
The relationship between the incidence of end-stage renal disease and markers of socioeconomic disadvantage. (2002) (23)
Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL. (2017) (23)
Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study. (2016) (23)
Patients’ and Providers’ Perspectives of a Polypill Strategy to Improve Cardiovascular Prevention in Australian Primary Health Care: A Qualitative Study Set Within a Pragmatic Randomized, Controlled Trial (2015) (23)
Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment (2015) (23)
The Effect of a Cardiovascular Polypill Strategy on Pill Burden. (2015) (22)
Disparities between Prescribing of Secondary Prevention Therapies for Stroke and Coronary Artery Disease in General Practice (2012) (22)
Getting it Right: validating a culturally specific screening tool for depression (aPHQ‐9) in Aboriginal and Torres Strait Islander Australians (2019) (22)
Community Preferences for the Allocation of Donor Organs for Transplantation: A Discrete Choice Study (2013) (21)
Investigating the feasibility, acceptability and appropriateness of outreach case management in an urban Aboriginal and Torres Strait Islander primary health care service: a mixed methods exploratory study (2016) (21)
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications (2015) (21)
The cost-effectiveness of early detection and intervention to prevent the progression of chronic kidney disease in Australia (2006) (21)
Rationing scarce organs for transplantation: healthcare provider perspectives on wait‐listing and organ allocation (2013) (21)
Impact of CKD on Household Income (2017) (20)
Impact of CKD on Household Income (2017) (20)
The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes. (2010) (20)
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network (2013) (20)
The use of psychosocial criteria in Australian patient selection guidelines for kidney transplantation. (2007) (19)
Design and participant baseline characteristics of ‘A Clinical Trial of IntensiVE Dialysis’: The ACTIVE Dialysis Study (2015) (19)
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial (2019) (19)
Patient Preferences for a Polypill for the Prevention of Cardiovascular Diseases (2015) (19)
Intensive glycemic control and renal outcome. (2011) (19)
Gathering Perspectives ‐ Finding Solutions for Chronic and End Stage Kidney Disease (2018) (19)
My experiences with kidney care: A qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation (2019) (19)
A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management (2017) (18)
Angiotensin‐converting enzyme inhibitor usage and acute kidney injury: A secondary analysis of RENAL study outcomes (2014) (18)
Interventions for lowering plasma homocysteine levels in kidney transplant recipients. (2015) (18)
Periodontal disease and chronic kidney disease among Aboriginal adults; an RCT (2015) (18)
Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial. (2015) (17)
New tools for an old trade: a socio-technical appraisal of how electronic decision support is used by primary care practitioners. (2011) (17)
“How can I do more?” Cultural awareness training for hospital-based healthcare providers working with high Aboriginal caseload (2020) (17)
The Fabric of Aboriginal and Torres Strait Islander Wellbeing: A Conceptual Model (2021) (17)
Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR Study. (2017) (17)
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial (2014) (17)
Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base. (2015) (16)
Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial (2008) (16)
Comorbidity recording and predictive power of comorbidities in the Australia and New Zealand dialysis and transplant registry compared with administrative data: 2000–2010 (2016) (16)
Bridging the treatment gap for Indigenous Australians. Demands for efficiency should not be met at the expense of equity. (2005) (16)
Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol (2019) (16)
Screening and Study Enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial (2009) (16)
Getting it Right: study protocol to determine the diagnostic accuracy of a culturally-specific measure to screen for depression in Aboriginal and/or Torres Strait Islander people (2016) (15)
Sex and mortality in septic severe acute kidney injury (2019) (15)
To your door: factors that influence Aboriginal and Torres Strait Islander peoples seeking care (2014) (15)
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease (2016) (15)
Interesting times ' evolution of dialysis in Australia's Northern Territory (1980-2014) (2018) (15)
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial (2015) (14)
Community preferences for the allocation of deceased donor organs for transplantation: a focus group study. (2013) (14)
What Matters 2 Adults: a study protocol to develop a new preference-based wellbeing measure with Aboriginal and Torres Strait Islander adults (WM2Adults) (2020) (13)
Renal‐related deaths in Australia 1997−1999 (2004) (13)
Community Preferences for the Allocation &Donation of Organs - The PAraDOx Study (2011) (13)
Serum vitamin D levels, diabetes and cardio-metabolic risk factors in Aboriginal and Torres Strait Islander Australians (2014) (13)
Organ Transplantation in Australia: Inequities in Access and Outcome for Indigenous Australians. (2017) (13)
Baseline characteristics of the omega‐3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study (2016) (12)
Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. (2008) (12)
Chronic kidney disease and socio-economic status: a cross sectional study (2020) (12)
The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study (2019) (12)
Quality of life in caregivers compared with dialysis recipients: The Co‐ACTIVE sub‐study of the ACTIVE dialysis trial (2019) (12)
Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial (2017) (12)
Long-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Regional and Remote Hospitals. (2016) (12)
Economic and quality of care evaluation of dialysis service models in remote Australia: protocol for a mixed methods study (2017) (11)
How fair is Medicare? The income‐related distribution of Medicare benefits with special focus on chronic care items (2012) (11)
The IMPAKT study: using qualitative research to explore the impact of end-stage kidney disease and its treatments on aboriginal and Torres Strait Islander Australians (2013) (11)
Central Australia Renal Study: Technical Report Update: Report prepared by Menzies School of Health Research for the Australian Government Department of Health (2016) (11)
Increasing home‐based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis (2011) (11)
Strengthening Innovation in an Australian Indigenous Primary Health Care Setting through Developmental Evaluation (2015) (11)
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study (2020) (11)
From “stuck” to satisfied: Aboriginal people’s experience of culturally safe care with interpreters in a Northern Territory hospital (2021) (11)
Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources (2018) (11)
Higher versus Lower Continuous Renal Replacement Therapy Intensity in Critically ill Patients with Liver Dysfunction (2017) (11)
Facilitators and barriers to implementation of a pragmatic clinical trial in Aboriginal health services (2015) (11)
Interventions for lowering plasma homocysteine levels in dialysis patients. (2016) (11)
Hyperfiltration in Indigenous Australians with and without diabetes. (2015) (11)
The influence of chronic kidney disease and age on revascularization rates and outcomes in acute myocardial infarction – a cohort study (2017) (10)
Kidney disease: are you at risk? (2002) (10)
Implementing Kanyini GAP, a pragmatic randomised controlled trial in Australia: findings from a qualitative study (2015) (10)
Challenges in blood pressure measurement in patients treated with maintenance hemodialysis. (2012) (10)
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection (2017) (10)
The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes. (2010) (10)
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection (2017) (10)
Kidney disease in Aboriginal and Torres Strait Islander peoples (2007) (10)
Varying Association of Extended Hours Dialysis with Quality of Life. (2019) (10)
Chronic kidney disease in aboriginal Australians (2005) (10)
Effectiveness of Wellbeing Intervention for Chronic Kidney Disease (WICKD): results of a randomised controlled trial (2020) (10)
Adapting wellbeing research tools for Aboriginal and Torres Strait Islander people with chronic kidney disease (2019) (10)
Models of care for co‐morbid diabetes and chronic kidney disease (2018) (9)
A review of linked health data in Australian nephrology (2016) (9)
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial (2015) (9)
Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study (2020) (9)
The HONEYPOT Randomized Controlled Trial Statistical Analysis Plan (2013) (9)
Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis (2017) (9)
Resting heart rate, physiological stress and disadvantage in Aboriginal and Torres Strait Islander Australians: analysis from a cross-sectional study (2016) (9)
Epidemiology of RBC Transfusions in Patients With Severe Acute Kidney Injury: Analysis From the Randomized Evaluation of Normal Versus Augmented Level Study* (2016) (9)
Aborigines and Uranium: Monitoring the Health Hazards (2006) (8)
Blood pressure among Australian Aboriginal children (2017) (8)
Sharing the true stories - improving communication between Aboriginal patients and health carers (2005) (8)
Sharing the true stories: improving communication between health staff and Aboriginalpatients, Stage 1, Interim project report (2005) (8)
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data (2020) (8)
Predictors of Arteriovenous Fistula Failure: A Post Hoc Analysis of the FAVOURED Study. (2020) (8)
Risk Factors for Stroke in People with End-Stage Kidney Disease: A Cohort Study (2016) (8)
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics (2021) (8)
Rural Versus Urban Health Service Utilization and Outcomes for Renal Patients in New South Wales: Protocol for a Data Linkage Study (2015) (8)
Incorporating indigenous knowledge in health services: a consumer partnership framework. (2019) (8)
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (2020) (7)
Bilirubin concentration is positively associated with haemoglobin concentration and inversely associated with albumin to creatinine ratio among Indigenous Australians: eGFR Study. (2017) (7)
Interventions to aid employment for people on dialysis and their families (2017) (7)
Prevalence and risk factors of prediabetes after renal transplantation : a single-centre cohort study in 200 consecutive patients (7)
What Matters 2 Adults (WM2Adults): Understanding the Foundations of Aboriginal and Torres Strait Islander Wellbeing (2021) (7)
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial (2016) (7)
Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease. (2019) (7)
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease (2017) (6)
The rationale and design of the Beta‐blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study (2015) (6)
Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease. (2016) (6)
Cross‐sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study (2018) (6)
Eff ects of fi brates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (6)
Oral health of aboriginal people with kidney disease living in Central Australia (2021) (6)
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease (2019) (6)
Indigenous patient voices: Gathering perspectives - finding solutions for chronic and end stage kidney disease, 2017 symposium report (2017) (6)
Do remote dialysis services really cost more? An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings (2021) (6)
Why it Remains Difficult for Remote Cardiologist to Obtain the Locus ofControl for Ambulatory Health Care Conditions Such as Congestive HeartFailure (2014) (6)
Cost of dialysis therapies in rural and remote Australia – a micro-costing analysis (2019) (6)
Applying evidence into routine clinical care at a unit level: The exemplar of renal anaemia management (2010) (6)
Incident haemodialysis and outcomes in the Top End of Australia. (2020) (6)
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial (2020) (5)
Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study (2020) (5)
Preventing chronic disease to close the gap in life expectancy for Indigenous Australians. (2012) (5)
Glucose lowering therapies for chronic kidney disease and kidney transplantation (2012) (5)
Understanding implementability in clinical trials: a pragmatic review and concept map (2021) (5)
Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study. (2019) (5)
Projecting demands for renal replacement therapy in the Northern Territory: a stochastic Markov model. (2017) (5)
CARPA Standard Treatment Manual: a clinic manual for primary health care practitioners in remote and Indigenous health services in Central and Northern Australia (2014) (5)
Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD (2020) (4)
High prevalence of chronic kidney disease in (2008) (4)
Effects of health service geographic accessibility in patients with treated end stage kidney disease: Cohort study 2000–2010 (2017) (4)
Closing the Gap for Indigenous Australians with chronic kidney disease: Research, policy and practice [Plenary speaker] (2011) (4)
Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial (2008) (4)
‘We’re here to listen and help them as well’: a qualitative study of staff and Indigenous patient perceptions about participating in social and emotional wellbeing research at primary healthcare services (2019) (4)
Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study. (2020) (4)
Barriers to accounting Australian Indigenous students ’ experience (2015) (4)
Complex needs and limited resources: Influences on the provision of primary healthcare to Aboriginal and Torres Strait Islander peoples living with chronic disease (2014) (4)
HMG‐CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes (2019) (4)
Performance of cardiovascular risk prediction equations in Indigenous Australians (2020) (3)
Difficult Conversations: discussing organ donation and transplantation with Aboriginal and Torres Strait Islander Australians (2006) (3)
Post-Hoc Subgroup Analysis of a Randomized Controlled Trial Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease: A (2010) (3)
Trajectories of eGFR decline over a four year period in an Indigenous Australian population at high risk of CKD-the eGFR follow up study. (2018) (3)
Updates on baseline characteristics of the omega‐3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study (2017) (3)
Barriers and enablers to implementing and using clinical decision support systems for chronic diseases: a qualitative systematic review and meta-aggregation (2022) (3)
Robust data to close the gap: current vascular and maternal/newborn indicators as measures of progress in Aboriginal health in New South Wales (2010) (3)
Introduction: The case for updating and context (2012) (3)
Review: An Australian model of care for co-morbid diabetes and chronic kidney disease. (2018) (3)
Cost effectiveness of renal replacement therapy for patients with end-stage kidney disease: a Markov microsimulation model (2006) (3)
REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach (REDUCCTION) - design and baseline results. (2020) (3)
Evaluation of ‘Ask the Specialist’: a cultural education podcast to inspire improved healthcare for Aboriginal peoples in Northern Australia (2022) (3)
1130-P: Temporal Trends in Pharmacotherapy for Diabetes (2019) (3)
Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial (2016) (3)
Qualitative study of psychosocial factors impacting on Aboriginal women’s management of chronic disease (2020) (3)
Queensland Statewide Renal Health Services Plan 2007-2017 - Part Two: Current service analysis and future demand predictions.Queensland Government (2007) (3)
“The talking bit of medicine, that’s the most important bit”: doctors and Aboriginal interpreters collaborate to transform culturally competent hospital care (2021) (3)
Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort (2019) (3)
Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease (2011) (3)
The relationship between proteinuria and cardiovascular disease: a systematic review (2009) (3)
Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria ‐ the eGFR Follow‐up Study (2018) (3)
Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis (2021) (3)
Impact of supplemental private health insurance on dialysis and outcomes (2020) (3)
LONG-TERM PROGNOSTIC VALUE OF ASPIRIN NON-RESPONSIVENESS AND PLATELET REACTIVITY AFTER ACUTE VASCULAR EVENTS: A POPULATION-BASED PROSPECTIVE COHORT STUDY (2009) (2)
Multifaceted intervention to reduce haemodialysis catheter related bloodstream infections: REDUCCTION stepped wedge, cluster randomised trial (2022) (2)
Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study (2020) (2)
Glomerular filtration rate and the risk of stroke (2010) (2)
Queensland Statewide Renal Health Services Plan 2007-2017 - Part Three: Economic modelling report: modelling the current and future costs and benefits of renal replacement therapy in Queensland. Queensland Government (2007) (2)
Outcomes associated with extended hours haemodialysis (EHHD) (2010) (2)
Dietary Fructose and Elevated Levels of Blood Pressure (2010) (2)
GLOMERULAR NUMBER, GLOMERULAR VOLUME AND KIDNEY WEIGHT IN FORENSIC AUTOPSIES: A MULTIRACIAL STUDY (2002) (2)
Using web conferencing to engage Aboriginal and Torres Strait Islander young people in research: a feasibility study (2020) (2)
Intensity of renal replacement therapy in critically ill patients: The randomized evaluation of normal versus augmented level renal replacement therapy (RENAL) Study (2009) (2)
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial. (2022) (2)
The predictive ability of different measures of kidney function: new data from the Progress study (2006) (2)
Early renal impairment: the role of the GP (2002) (2)
Psychosocial criteria in Australian practice guidelines for determining patient suitability for kidney transplantation (2006) (2)
Comparative efficacy of a team‐led treatment protocol for the management of renal anaemia (2013) (2)
The fork in the road: exploring factors which influence whether Aboriginal and Torres Strait Islander peoples living with chronic disease remain engaged with health services (2014) (2)
Effectiveness, cost effectiveness, acceptability and implementation barriers/facilitators of chronic kidney disease management programs and models of care for Aboriginal and Torres Strait Islander Australians: a mixed methods systematic review protocol (2015) (2)
Preface – Advances in CKD 2018 (2018) (2)
Health-related Quality of Life in Survivors of Acute Kidney Injury: the Post-RENAL Study Outcomes (2015) (2)
TWENTY YEAR CANCER OUTCOMES OF A RANDOMISED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL: 288 (2008) (2)
Adding measures of body composition to the CKD-EPI GFR estimating equation in Indigenous Australians: the eGFR study. (2015) (2)
Central Australia Renal Study: Final Report (2011) (2)
Queensland Statewide Renal Health Services Plan 2007-2017 - Part One: the way forward (2007) (2)
END‐STAGE RENAL DISEASE (ESRD) IN INDIGENOUS AUSTRALIANS: A DISEASE OF POVERTY (2000) (2)
Dementia in Aboriginal people in Residential Aged Care Facilities in Alice Springs: A Descriptive Study (2019) (2)
The impact of vicarious trauma on Aboriginal and/or Torres Strait Islander health researchers. (2020) (2)
Representativeness of Honeypot Trial Participants to Australasian PD Patients (2017) (2)
Medicare Benefits Schedule Review Taskforce: Report from the Renal Clinical Committee (2017) (1)
DETERMINANTS AND EFFECT OF LATE REFERRAL (LR) IN AUSTRALIA (2000) (1)
Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population (2010) (1)
Using Pharmaceutical Benefit Scheme data to understand the use of smoking cessation medicines by Aboriginal and Torres Strait Islander smokers (2021) (1)
Improving Indigenous Health: a review of the current status of remote area renal services for Indigenous Australians and identification of barriers to their accessing needed services (2004) (1)
All they said was my kidneys were dead: Indigenous Australian patients’ understanding of their kidney disease (2008) (1)
Factors associated with survival in elderly dialysis patients (2010) (1)
A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial (2014) (1)
Interventions for erythropoietin-resistant anaemia in dialysis patients: a systematic review (2010) (1)
CONSIDER – CONSIDERATIONS OF NEPHROLOGISTS WHEN SUGGESTING DIALYSIS IN ELDERLY PATIENTS WITH RENAL FAILURE (2013) (1)
Design, effectiveness, and economic outcomes of contemporary chronic disease clinical decision support systems: a systematic review and meta-analysis (2022) (1)
THE ROLE OF TUMOUR NECROSIS FACTOR RECEPTOR 1 (TNFR1) IN THE PROGRESSION OF KIDNEY DISEASE IN INDIGENOUS AUSTRALIANS: THE EGFR FOLLOW-UP STUDY (2017) (1)
Epidemiology and outcome research in CKD 5D (2012) (1)
Patient Preferences for the Allocation of Deceased Donor Kidneys for Transplantation: A Mixed Methods Study: 946 (2012) (1)
Access to renal transplantation for minority patients with end-stage renal disease in Canada (2004) (1)
Dialysis attendance patterns and health care utilisation of Aboriginal patients attending dialysis services in urban, rural and remote locations (2022) (1)
Obesity and 5 year incidence of kidney disease - findings from AusDiab (2007) (1)
Mini Orals (2018) (1)
Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study (2009) (1)
Central Australia renal study technical report update (2016) (1)
Validation and Evaluation of Memorial Symptom Assessment Scale Short-Form (Msas-Sf)In a Romanian Cohort of Hemodialysis Patients (2015) (1)
Symptom burden in a palliative nephrology clinic (2010) (1)
Acute kidney injury in Indigenous Australians: an unrecognised priority for action (2019) (1)
A PRAGMATIC TRIAL OF A POLYPILL-BASED STRATEGY TO IMPROVE ADHERENCE TO INDICATED PREVENTIVE TREATMENTS AMONG PEOPLE AT HIGH CARDIOVASCULAR DISEASE RISK (2013) (1)
Beyond the biomedical perspective: how social factors determine renal disease (2003) (1)
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (Preprint) (2019) (1)
Can A Cvd Polypill Save Money In The 'Real World'? (2014) (1)
Lessons learned from a periodontal intervention to reduce progression of chronic kidney disease among Aboriginal Australians (2020) (1)
The 'Communicate' study: Improving communication with hospitalised Aboriginal patients to ensure quality and safety in healthcare (2018) (1)
Development of learning strategies and resources to teach health care students cross-cultural interviewing skills (2010) (1)
Retrospective Audit of Rheumatic Heart Valve Surgical Outcomes in the Top End of Northern Territory, Australia (2017) (1)
Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis (2020) (1)
Anthropometric Profile in Indigenous Australians in the eGFR Study (2017) (1)
Opening doors: Evaluation of Maari Ma Health Aboriginal Corporation’s chronic disease strategy (2016) (1)
O105 Effect Of A Multi-Faceted Quality Improvement Intervention To Improve Cardiovascular Disease Risk Identification And Management In Australian Primary Health Care: The Torpedo Cluster-Randomised Trial (2014) (1)
Tasmania State Plan for renal services 2010-2020 — Part One: Overview and action plan (2009) (1)
Hospitalized fracture rates amongst patients with chronic kidney disease in Australia using data linkage (2019) (1)
How might research be translated to improved access and health outcomes for Indigenous Australians with end-kidney disease (2005) (0)
Cross-national perspectives on patient safety. Background paper to the China Health Policy Roundtable (2005) (0)
Blood pressure in dialysis patients—look before we leap – Authors' reply (2009) (0)
SAT-241 SMALL AREA-LEVEL VARIATION IN CHRONIC KIDNEY DISEASE PREVALENCE AND INCIDENCE IN NEW SOUTH WALES (2019) (0)
Options for Clinical Services: Provision of renal prevention and treatment services (2003) (0)
Fish oil and aspirin effects on arteriovenous fistula function Omega-3 Fatty Acids Fish Oils (2019) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Association of Baseline Concentrations of Liver Function Tests and Full Blood Count Indices with Annual eGFR Decline and Renal Outcomes in Aboriginal and Torres Strait Islander People: The eGFR Follow- Up Study (2020) (0)
A DYNAMIC VIEW OF DIALYSIS MODALITY AND SURVIVAL (2002) (0)
Type 2 diabetes guideline series: diabetic retinopathy and chronic kidney disease (2009) (0)
A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS – HONEYPOT STUDY (2013) (0)
Timing of nephrology referral: a study of its effects on the likelihood of transplantation and impact on mortality (2002) (0)
DIALYSIS. EPIDEMIOLOGY, OUTCOME RESEARCH, HEALTH SERVICES 1 (2014) (0)
Chronic kidney disease and the heart: beyond the drive-by angiogram (2006) (0)
Kimberley Renal Services Project. Prepared for the WA Country Health Services and Kimberley Renal Advisory Group (2006) (0)
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009) (2009) (0)
Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial (2022) (0)
Addressing the social determinants of chronic disease amongst Indigenous Australians (2012) (0)
[Keynote speaker] The Epidemic of End-Stage Kidney Disease in the Asia-Pacific Region: We must act now (2010) (0)
SUN-129 ACTIVATION LEVELS AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE ATTENDING A CO-DESIGNED INTEGRATED MODEL OF CARE: A LONGITUDINAL STUDY (2020) (0)
The Australasian Kidney Trial Network: Current and future trials (2008) (0)
Is there a safe and high quality care for Aboriginal and Torres Strait Islander peoples: A perspective from the Kanyini Vascular Collaboration (Chapter 4) (2010) (0)
The Central Australia Renal Study – Can we provide sustainable and appropriate renal services to Aboriginal people from remote communities across the region? [Invited speaker] (2011) (0)
Why do governments intervene in health (2003) (0)
Front & Back Matter (2013) (0)
An omega 3 fatty acid supplemented diet was not associated with enhanced survival in maintenance haemodialysis: the Fish and Fruit Study (2020) (0)
The identification and management of chronic kidney disease (CKD) and risk factors in aboriginal primary health care (2008) (0)
SUN-119 COMPARING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THREE COUNTRIES - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER) (2020) (0)
Impact of Private Health Insurance on Dialysis Outcomes - A Cohort Study (2017) (0)
Simpler solutions to prevent chronic disease: A polypill-based strategy to prevent major cardiovascular events. (2011) (0)
Cardiovascular disease in end-stage kidney disease (2005) (0)
Infection-Related Hospitalisations Across Different Levels Of Kidney Function: Data From The Extend45 Study (2018) (0)
A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care. (2021) (0)
699 Impact of Adherence to Antibiotic Prophylaxis on Rheumatic Heart Valve Surgical Outcomes in the Northern Territory of Australia (2020) (0)
Rationale for the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE) (2011) (0)
Methodology of the ATSI egfr study: accurate assessment of renal function in indigenous Australians (2008) (0)
1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence (2019) (0)
SAT-184 Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study (2019) (0)
RENAL Study Investigators Association of ACEI use and AKI outcomes: an observational analysis of the Randomised Evaluation of Normal vs. Augmented Level of replacement therapy (RENAL) trial. (2013) (0)
Research priorities in chronic kidney disease: a priority setting partnership (2014) (0)
[Reply] Blood pressure in dialysis patients-look before we leap (2009) (0)
Cardiovascular complications - 2 (2009) (0)
Abstract 14374: Performance of ACC/AHA Cardiovascular Disease Risk Equations in Indigenous Australians With and Without Diabetes: The CRISP Study Collaboration (2018) (0)
Longest running Aboriginal health study to enter new stage (2017) (0)
Achieving best outcomes in managing chronic disease in vulnerable patients (2006) (0)
Chronic kidney disease screening in Aboriginal communities in the Hunter New England Health region (2007) (0)
Global burden of CKD: Differences throughout the world [Invited speaker] (2011) (0)
Lipid lowering in chronic kidney disease (2009) (0)
Protocol Rural Versus Urban Health Service Utilization and Outcomes for Renal Patients in New South Wales : Protocol for a Data Linkage Study (2018) (0)
Steps or marathon? Distance and remoteness as influences on access to transplant for Australian indigenous patients with end-stage kidney disease (ESKD) (2008) (0)
Delayed Resolution of an Extensive Dermatophyte Infection: Client and Clinician Perceptions of Treatment Response in an Adult Dependent on Haemodialysis (2017) (0)
Time to act: a research agenda to improve Aboriginal health (2007) (0)
ESTIMATING EFFECTS OF SYSTEMATIC TREATMENT ON RENAL FAILURE AND DEATH WITHOUT A PARALLEL PLACEBO CONTROL GROUP (2000) (0)
Screening for kidney problems in the elderly (2003) (0)
Factors Associated With Regression Of Left Ventricular Mass Index In The Active Dialysis Trial (2018) (0)
Transplants at the end of the galaxy - health system barriers for remote and isolated patients (2005) (0)
A Process Evaluation of the National Implementation of a Bundle for Central Venous Catheter Care for Hemodialysis (2023) (0)
Predicting future requirements for renal replacement therapy in Australia (2006) (0)
EDS tool for the management of chronic disease [Invited speaker] (2011) (0)
The RENAL Study - randomised evaluation of normal versus augmented levels of renal replacement therapy in severe acute kidney injury (2009) (0)
Central Australia Renal Study: Technical Report and Technical Appendices (2011) (0)
Trajectories of eGFR decline over a four year period: the eGFR follow up study (2017) (0)
Cost-effective chronic disease treatment - targeting global risk to prevent death and avoidable hospitalization. Plenary presentation (2007) (0)
POS-301 IMPROVING THE IDENTIFICATION AND MANAGEMENT OF KIDNEY DISEASE THROUGH AN INTEGRATED CLINICAL INFORMATION PLATFORM AND DECISION SUPPORT TOOL (2021) (0)
HEAL – Australian Research Network in Human Health and Environmental Change (2022) (0)
The relationship between chronic kidney disease and individual-level socio-economic factors: the three country kidney disease study (3CKD) (2006) (0)
Β-receptor antagonists in advanced chronic kidney disease: a systematic review and meta-analysis (2010) (0)
The Identification and management of vascular diseases and their risk factors in eight Indigenous primary health care services--The results of the Kanyini Vascular Collaboration Audit study (2008) (0)
Healthy Environments and Lives (HEAL): Australian research network in human health and environmental change. (2022) (0)
Integrated medical care for indigenous communities – what is it and how do we do it? (2011) (0)
Twenty year cancer outcomes of a randomised trial of immunosuppression in kidney recipients: results of the Australian multi-centre trial of cyclosporine withdrawal (2007) (0)
Cost effectiveness of screening for the early diagnosis and treatment of factors for chronic kidney disease: a Markov Monte-Carlo microsimulation using MARCK-E (Model for the Assessment of Risk factors for Chronic Kidney disease – Economics) (2006) (0)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (2010) (0)
Conducting health economic research in kidney disease and Government regulation andpayment systems for renal replacement therapy (2007) (0)
The authors respond (2004) (0)
A Broader View of Renal Disease: Findings in Aboriginal Australia (2002) (0)
Lower blood pressure and the risk of recurrent stroke in patients with chronic kidney disease: results of the PROGRESS trial (2008) (0)
Chronic kidney disease epidemiology in Australia - highlighting the excess burden of disease among Indigenous Australians (2005) (0)
DELAYED REFERRAL WORSENS LONG-TERM SURVIVAL ON DIALYSIS (2002) (0)
Association of neuropathy and physical parameters in people on maintenance haeomdialysis: a prospective study (2016) (0)
Development and validation of algorithms to identify patients with chronic kidney disease and related chronic diseases across the Northern Territory, Australia (2022) (0)
Chronic kidney disease: managing and preventing the burden of disease (2006) (0)
ANZSN Program at a Glance (2015) (0)
Report of the China Health Care Safety Roundtable: A report to the China Ministry of Health (2005) (0)
Inequity in health system access and outcomes: we can make a difference (2007) (0)
Abstract 19278: The Impact of Chronic Kidney Disease on Clinical Outcomes in Patients Admitted with Acute Myocardial Infraction in an Australian Setting (2012) (0)
[Keynote speaker] Economics of home-based dialysis therapies (2010) (0)
Inequity and health, a call to action, addressing health and socioeconomic inequality in Australia (2005) (0)
Australian nephrologists' attitudes towards living kidney donation: results from a national survey (2006) (0)
Health targets for closing the gap in life expectancy between Indigenous and nonindigenous Australians (2008) (0)
A research agenda to close the gap in health outcomes for Indigenous Australians [Keynote speaker] (2011) (0)
Management of chronic kidney disease in Australian general practice (the AusHEART Study) (2010) (0)
Late referral and access to renal transplantation. Authors' reply (2004) (0)
All they said was my kidneys were dead: Indigenous Australian kidney disease patients' understanding of their health and illness and perspectives on their interactions with the healthcare system (2008) (0)
Addressing the burden of chronic disease to close the gap in Indigenous health outcomes: Research, policy and practice [Plenary speaker] (2011) (0)
Contents Vol. 37, 2014 (2014) (0)
Outcomes in rural versus urban end stage kidney disease in New South Wales using data linkage (2013) (0)
Proteinuria as a predictor of stroke – a systematic review (2007) (0)
REnal Disease ( FAVOURED ) study (2015) (0)
Tasmania State Plan for renal services 2010-2020 — Part Three: Economic modelling report: Modelling the current and future costs and benefits of renal replacement therapy in Tasmania (2009) (0)
Exploring the roles and responsibilities Aboriginal women have within their families and community and how they impact on management of their chronic disease (2013) (0)
Timing of renal replacement therapy and risk of death: a pooled observational analysis of 5 randomised trials (2016) (0)
Renal results from the ADVANCE study (2012) (0)
Association of Dialysis Attendance with Waitlisting of Northern Territory (NT) Based End Stage Kidney Disease (ESKD) Patients (2017) (0)
Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction (2022) (0)
Awareness of personal risk of CKD amongst the general community (2006) (0)
The Kanyini Vascular Collaboration: Improving the management of chronic vascular/metabolic disease (2008) (0)
Multidisciplinary management of complex chronic disease - the case for an absolute risk-based management strategy (2007) (0)
Difficult conversations: Australian Indigenous patients' views on kidney transplantation (2017) (0)
Tasmania State Plan for renal services 2010-2020 — Part Two: Challenges for the department and future projections (2009) (0)
Social determinants of end-stage renal disease (2002) (0)
Government regulation and payment systems for renal replacement therapy. Plenary presentation (2007) (0)
Psychosocial criteria in Australian practice guidelines for determining patient suitability for kidney donation (2006) (0)
A randomised trial of fish and fruit to improve survival of people on maintenance dialysis (2006) (0)
SAT-288 Trends in pharmacotherapy for diabetes in a large Australian cohort: results from the EXTEND45 study (2019) (0)
ANZSN Renal Scientists Workshop (2015) (0)
Outcomes in home extended hours haemodialysis (HEHHD) (2010) (0)
ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY (2018) (0)
Clinical outcomes in NSW patients admitted with AMI and chronic kidney disease (2012) (0)
Closing the gap: Too many Indigenous Australians are dying too young with chronic disease (2012) (0)
Sharpening the impact of Aboriginal health research (2005) (0)
Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic review (2022) (0)
Improving Indigenous Health: Strategies to improve access, timeliness and quality of remote area renal services for Indigenous Australians (2004) (0)
SAT-047 REASONS FOR DIALYSIS CATHETER INSERTION – REAL TIME DATA FROM THE REDUCCTION PROJECT (2019) (0)
Abstracts of the 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, 25-27 August, 2014, Melbourne, Australia. (2014) (0)
Kanyini Vascular Collaboration – Findings about Strategies to Improve Cardiovascular Disease Risk Management for Aboriginal People [Invited speaker] (2011) (0)
New approaches to CVD in Indigenous communities (2006) (0)
A randomised, controlled trial of exit site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients: The HONEYPOT study (2009) (0)
THE SHARP-ER STUDY: DESIGN OF THE EXTENDED FOLLOW-UP OF THE SHARP STUDY COHORT (2015) (0)
Diabetes, heart and kidney disease: The health reform challenge we must address (2010) (0)
Supplementary Material for: Risk Factors for Stroke in People with End-Stage Kidney Disease: A Cohort Study (2016) (0)
Public hospitals and medical research - Where now? (2009) (0)
702 Long-Term Survival and Predictors of Outcomes of Indigenous Northern Territorians Undergoing Primary and Re-Do Surgery for Rheumatic Heart Disease in Australia (2020) (0)
INFERR-Iron Infusion in Haemodialysis Study: INtravenous Iron Polymaltose for First Nations Patients With High FERRitin Levels On Haemodialysis A Protocol for a Prospective Open-Label Blinded Endpoint Randomised Controlled Trial (2021) (0)
CLINICAL ACUTE KIDNEY INJURY 1 (2014) (0)
Renal complications in Australian indigenous communities (2006) (0)
Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol (2019) (0)
Reductions in the risk of vascular events and stroke in patients with and without chronic kidney disease; new data from the PROGRESS trial (2006) (0)
The cost-effectiveness of targeted screening for chronic kidney disease. Plenary presentation (2007) (0)
Nephrology and Transplantation Update Course (2015) (0)
Lessons learned from the SHARP study: collaborating to address priority research questions in nephrology (2006) (0)
Some issues to consider when assessing concordance of death certificates with registry reports (2004) (0)
OUTCOMES WITH RENAL TRANSPLANTATION IN INDIGENOUS AUSTRALIANS (2002) (0)
The efficacy of lower blood pressure goals on the prevention of stroke in chronic kidney disease: data from the PROGRESS study (2007) (0)
Closing the gap: addressing the burden of complex chronic disease among Indigenous Australians (2008) (0)
Predictors of health-related quality of life in survivors following acute kidney injury: a secondary analysis of Post-RENAL study outcomes (2014) (0)
Oral health of aboriginal people with kidney disease living in Central Australia (2021) (0)
COMPARISON OF INDIGENOUS AND NON-INDIGENOUS PERITONEAL DIALYSIS COMPLICATIONS AND OUTCOME IN THE TOP END (2000) (0)
Effects of Fibrates in Chronic Kidney Disease across studies (2012) (0)
Ultrasound Imaging for R gional Anesthesia in Infants , Children , and Adolescents (2013) (0)
Interventions for lowering plasma homocysteinelevels in kidney transplant recipients [Protocol] (2009) (0)
Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection‐extended review (2022) (0)
Exploring the pathways leading from disadvantage to ESRD for indigenous Australians (2003) (0)
Relative Contributions To Major Dialysis Randomised Controlled Trials From Ten Global Regions (2018) (0)
SAT-289 Association between the intensity of diabetes pharmacotherapy regimens, persistence and achieved HbA1c in a large Australian cohort: results from the EXTEND45 study (2019) (0)
Challenges to the provision of sustainable and appropriate renal services to Aboriginal people from remote communities (2012) (0)
Surgery for rheumatic heart disease in the Northern Territory, Australia, 1997–2016: what have we gained? (2023) (0)
DISADVANTAGE AND VARIATION IN THE INCIDENCE OF ESRD IN AUSTRALIAN CAPITAL CITIES (2002) (0)
Late referral in the eGFR era (2010) (0)
Preventing and treating kidney disease to improve health of indigenous Australians (2006) (0)
beta-RECEPTOR ANTAGONISTS IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS (2010) (0)
A Complex Intervention to Improve Intercultural Communication and Aboriginal Patient Outcomes: Which Components Worked? (2020) (0)
Managing chronic kidney disease across the continuum: is it achievable in regional and remote Australia? (2007) (0)
Making the list: decision making about patient suitability for kidney transplantation in Australia and Canada (2007) (0)
[Plenary speaker] Economic impact of the future of chronic kidney disease and transplantation in Australia (2010) (0)
Impact Of Extended Hours Dialysis On Utility-Based Quality Of Life: Results From The Active Dialysis Trial (2018) (0)
Chronic disease prevention, identification, management and care (2008) (0)
Differences in body build within Indigenous Australians may impact on estimates of renal function (2009) (0)
Home-based, Outreach case Management of chronic disease Exploratory (HOME) Study (2014) (0)
Exploring the burden of chronic kidney disease in Australia (2005) (0)
What are the big Commonwealth challenges in addressing chronic disease for Aboriginal and Torres Strait Islander people (2011) (0)
Charles Darwin University Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria-the eGFR Followup (2017) (0)
The economic impact of chronic kidney disease in Australia (2006) (0)
The stay strong app as a self-management tool for first nations people with chronic kidney disease: a qualitative study (2021) (0)
Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre-specified cross-sectionalstudy of the FAVOURED trial participants. (2021) (0)
Improving health outcomes for Aboriginal people with chronic disease (2008) (0)
Nephrologists’ attitudes to transplantation in Aboriginal (Indigenous) Australians (2006) (0)
Late referral and access to renal transplantation (2004) (0)
Kidney disease in 2020: a dialysis unit in every GP super clinic? [Plenary speaker] (2011) (0)
The ethics of research involving Canada's Aboriginal populations (2005) (0)
Mortality In Elderly Dialysis Patients: The Association With Demographic, Patient And Practice Variables (2009) (0)
TRANSLATIONAL CKD RESEARCH (2014) (0)
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial (2022) (0)
FP332RISK FACTORS FOR STROKE IN PEOPLE WITH END-STAGE KIDNEY DISEASE: A COHORT STUDY OF 10,745 PEOPLE (2015) (0)
2016 Abstract Reviewers (2016) (0)
Contents Vol. 42, 2016 (2016) (0)
Reply : Late referral and access to renal transplantation (2004) (0)
Using knowledge to safeguard our nations - A collaborative approach to vascular and renal health in Aboriginal communities within the countries of north-eastern NSW (2007) (0)
Dialysis and Transplantation News Australian nephrologists’ attitudes towards living kidney donation (2006) (0)
A Retrospective Case-Control Study Exploring Risk Factors for Loss of Kidney Transplant Function or Death Among Indigenous Transplant Recipients (2018) (0)
Working with populations in which there is disadvantage and inequity. Chair (2008) (0)
Quantitative evaluation of an outreach case management model of care for urban Aboriginal and Torres Strait Islander adults living with complex chronic disease: a longitudinal study (2020) (0)
Retrospective case–control study exploring pretransplant predictors for loss of kidney transplant function or death among indigenous kidney transplant recipients (2021) (0)
Increasing Australian pharmacy's role in meeting national and international antimicrobial resistance objectives (2018) (0)
Australian nephrologists’ attitudes towards living kidney donation (Conference Proceedings) (2006) (0)
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease (2014) (0)
How to treat chronic kidney disease in general practice (2007) (0)
IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE (2015) (0)
MAPPING THE INCIDENCE OF END-STAGE RENAL DISEASE (ESRD) IN INDIGENOUS AUSTRALIANS (2000) (0)
[Keynote speaker] Diabetic kidney disease: Epidemiology and Prevention (2010) (0)
[Plenary speaker] Recent evidence from cholesterol-lowering trials in patients with CKD (2012) (0)
Association of Dialysis Attendance with Kidney Transplant Outcomes in Northern Territory (Nt) Based Kidney Transplant Recipients (2017) (0)
20 year outcomes of the Australian multi-centre randomised trial of cyclosporine withdrawal in renal transplantation (2007) (0)
Domestic and international research collaborations in chronic kidney disease [Invited speaker] (2010) (0)
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial (2021) (0)
Renal-related deaths in Australia 1997-1999: an analysis of national mortality data (2004) (0)
Outcomes of patients receiving extended hours haemodialysis (Ehhd) (2011) (0)
Accurate assessment of kidney function in Indigenous Australians: the Egfr Study (2012) (0)
Diabetes, obesity and kidney disease: a perfect storm (2012) (0)
Tripterigium for the treatment of chronic kidney disease: a systematic review and meta-analysis (2012) (0)
Kidney Function, Glucose-Lowering Treatment And HBA1C Levels In People With Prevalent Diabetes: A Population-Based Cohort Study (Extend45) (2018) (0)
Facilitating Indigenous Australians’ access to medicines and necessary care [Plenary speaker] (2011) (0)
Implementing renal anaemia guidelines: using a standardised treatment algorithm at a unit level (2010) (0)
Kidney disease in disadvantaged populations (2005) (0)
Chronic diseases disparities for Aboriginal and Torres Strait Islander Australians: how should we address them? (2006) (0)
Research to improve health outcomes for Aboriginal people with complex chronic disease (2012) (0)
clinicians and researchers are to fulfil our obligation, we must first understand how we might inadvertently be contributing to the problem and then take steps to bridge the treatment gap. (2005) (0)
Albuminuria Is a Critical Determinant of Ckd Progression Among Indigenous Australian Adults: the Egfr Follow-Up Study (2015) (0)
Reducing disparities in Aboriginal health: dispelling myths and developing a research agenda to improve health (2007) (0)
Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alan Cass?

Alan Cass is affiliated with the following schools: